CSL

Founded in 1916 by the Australian government, CSL (Commonwealth Serum Laboratories) was privatized in 1994 and has since grown into a global biotechnology leader. The company's primary mission is to develop and manufacture medicines that treat and prevent serious human medical conditions. Its operations are driven by three main businesses: CSL Behring, which produces therapies derived from plasma; CSL Seqirus, one of the world's largest influenza vaccine providers; and CSL Vifor, a leader in iron deficiency and nephrology. CSL is committed to a promise of innovation and delivering for patients and public health worldwide.